Abstract
The interaction between roxithromycin and midazolam was investigated in a double-blind, randomised crossover study of two phases. Ten healthy volunteers were given roxithromycin (300 mg) or placebo once daily for 6 days. On the sixth day they ingested 15 mg midazolam. Plasma samples were collected and psychomotor performance measured for 17 h.
Roxithromycin administration significantly increased the area under the plasma midazolam concentration-time curve from 8.3 to 12.2 ώg·ml−1·min and the elimination half-lives from 1.7 to 2.2 h. In psychomotor performance only minor differences were seen between the treatments in one of the measured psychomotor parameters.
Thus, in contrast to the strong interaction between erythromycin and midazolam, the interaction between roxithromycin and midazolam appears less likely to be clinically significant.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aaltonen L, Himberg J-J, Kanto J, Vuori A (1981) The usefulness of radioreceptor assay and chromatography in pharmacokinetic studies. Int J Clin Pharmacol 23: 247–252
Allonen H, Ziegler G, Klotz U (1981) Midazolam kinetics. Clin Pharmacol Ther 30: 653–661
Billaud EM, Guillemain R, Fortineau N, Kitzis MD, Dreyfus G, Amrein C, Kreft-Jais C, Husson JM, Chretien P (1990) Interaction between roxithromycin and cyclosporin in heart transplant patients. Clin Pharmacokinet 19: 499–502
Bond A, Lader MH (1974) The use of visual analogue scales in rating subjective feelings. Br J Med Psychol 47: 211–218
Byatt CM, Lewis LD, Dawling S, Cochrane GM (1984) Accumulation of midazolam after repeated dosage in patients receiving mechanical ventilation in an intensive care unit. BMJ 289: 799–800
Editorial (1988) Midazolam — is antagonism justified? Lancet II: 140–142
Fee JPH, Collier PS, Howard PJ, Dundee JW (1987) Cimetidine and ranitidine increase midazolam bioavailability. Clin Pharmacol Ther 41: 80–84
Gascon M-P, Dayer P (1991) In vitro forecasting of drugs which may interfere with the biotransformation of midazolam. Eur J Clin Pharmacol 41: 573–578
Gibaldi M, Perrier D (1982) Pharmacokinetics. Dekker, New York
Griffiths AN, Marshall RW, Richens A (1984) Saccadic eye movements analysis as a measure of drug effects on human psychomotor performance. Br J Clin Pharmacol 18: 73–82
Hannington-Kiff JG (1970) Measurements of recovery from outpatient general anaesthesia with simple ovular test. BMJ 3: 132–135
Hashiguchi K, Niki Y, Soafima R (1992) Roxithromycin does not raise serum theophylline levels. Chest 102: 653–654
Hiller A, Olkkola KT, Isohanni P, Saarnivaara L (1990) Unconsciousness associated with midazolam and erythromycin. Br J Anaesth 65: 826–828
Houin G, Montastruc JL, Lequellec A, Bonnat C, Lenfant B (1992) A study of interaction of roxithromycin with theophylline. The Vth World Conference on Clinical Pharmacology and Therapeutics, Yokohama, 26–31 July 1992
Kronbach T, Mathys D, Umeno M, Gonzales FJ, Meyer UA (1989) Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4. Mol Pharmacol 36: 89–96
Larrey D, Funck-Brentano C, Briel P, Vitaux J, Theodore C, Babany G, Pessayre D (1983) Effects of erythromycin on hepatic drug-metabolizing enzymes in humans. Biochem Pharmacol 32: 1063–1068
Mattila MJ, Idänpään-Heikkilä JJ, Törnwall M, Vanakoski J (1993) Oral single doses of erythromycin and roxithromycin may increase the effects of midazolam on human performance. Pharmacol Toxicol 73: 180–185
Meyer B, Muller F, Wessels P, Maree J (1990) A model to detect interactions between roxithromycin and oral contraceptives. Clin Pharmacol Ther 47: 671–674
Olkkola KT, Aranko K, Luurila H, Hiller A, Saarnivaara L, Himberg J-J, Neuvonen PJ (1993) A potentially hazardous interaction between erythromycin and midazolam. Clin Pharmacol Ther 53: 298–305
Paulsen O, Nilsson LG, Saint-Salvi B, Manuel C, Lunell E (1988) No effect of roxithromycin on pharmacokinetic or pharmacodynamic properties of warfarin and its enantiomers. Pharmacol Toxicol 63: 215–220
Periti P, Mazzei T, Mini E, Novelli A (1992) Pharmacokinetic drug interactions of macrolides. Clin Pharmacokinet 23: 106–131
Saint-Salvi B, Tremblay D, Surjus A, Lefebure MA (1987) A study of the interaction of roxithromycin with theophylline and carbamazepine. J Antimicrob Chemother 20 [Suppl B]: 121–129
Smith JM, Misiak H (1976) Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects — A review. Psychopharmacology 47: 175–182
Stone BI (1984) Pencil and paper tests — sensitivity to psychotropic drugs. Br J Clin Pharmacol 18: 15–20
Tinel M, Descatoire V, Larrey D, Loeper J, Labbe G, Letterton P, Pessayre D (1989) Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides. J Pharmacol Exp Ther 250: 746–751
Wilkinson L (1988) Systat: system for statistics. Systat, Evanston, Illinois
Young RA, Gonzalez JP, Sorkin EM (1989) Roxithromycin: a review of it's antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 37: 8–41
Author information
Authors and Affiliations
Additional information
Presented in part at the 18th International Congress of Chemotherapy, Stockholm, Sweden, June 27–July 2, 1993
Rights and permissions
About this article
Cite this article
Backman, J.T., Aranko, K., Himberg, J.J. et al. A pharmacokinetic interaction between roxithromycin and midazolam. Eur J Clin Pharmacol 46, 551–555 (1994). https://doi.org/10.1007/BF00196114
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00196114